These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15912773)

  • 1. [Functional glycosylation and platelet-aggregation stimulating activity of Aggrus].
    Kaneko M
    Seikagaku; 2005 Apr; 77(4):332-5. PubMed ID: 15912773
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.
    Kato Y; Fujita N; Kunita A; Sato S; Kaneko M; Osawa M; Tsuruo T
    J Biol Chem; 2003 Dec; 278(51):51599-605. PubMed ID: 14522983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.
    Kaneko MK; Kato Y; Kitano T; Osawa M
    Gene; 2006 Aug; 378():52-7. PubMed ID: 16766141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis.
    Nakazawa Y; Sato S; Naito M; Kato Y; Mishima K; Arai H; Tsuruo T; Fujita N
    Blood; 2008 Sep; 112(5):1730-9. PubMed ID: 18541721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
    Kunita A; Kashima TG; Morishita Y; Fukayama M; Kato Y; Tsuruo T; Fujita N
    Am J Pathol; 2007 Apr; 170(4):1337-47. PubMed ID: 17392172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.
    Kaneko MK; Kato Y; Kameyama A; Ito H; Kuno A; Hirabayashi J; Kubota T; Amano K; Chiba Y; Hasegawa Y; Sasagawa I; Mishima K; Narimatsu H
    FEBS Lett; 2007 Jan; 581(2):331-6. PubMed ID: 17222411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
    Fujita N; Takagi S
    J Biochem; 2012 Nov; 152(5):407-13. PubMed ID: 22992842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of membrane glycoproteins in platelet adhesion and aggregation.
    Phillips DR
    Prog Hemost Thromb; 1980; 5():81-109. PubMed ID: 6775347
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors.
    Kato Y; Sasagawa I; Kaneko M; Osawa M; Fujita N; Tsuruo T
    Oncogene; 2004 Nov; 23(52):8552-6. PubMed ID: 15361850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning the available Dictyostelium discoideum proteome for O-linked GlcNAc glycosylation sites using neural networks.
    Gupta R; Jung E; Gooley AA; Williams KL; Brunak S; Hansen J
    Glycobiology; 1999 Oct; 9(10):1009-22. PubMed ID: 10521537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface labelling as a tool to determine structure-function relationships of platelet plasma membrane glycoproteins.
    Phillips DR
    Thromb Haemost; 1980 Feb; 42(5):1638-51. PubMed ID: 6768157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood platelet aggregation].
    Deguchi K; Murashima S; Shirakawa S
    Nihon Rinsho; 1981; 39(12):3765-74. PubMed ID: 6461781
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycoproteins IIb and IIIa and platelet thrombospondin in a liposome model of platelet aggregation.
    Rybak ME
    Thromb Haemost; 1986 Apr; 55(2):240-5. PubMed ID: 2940724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstruction of platelet proteins into phospholipid vesicles. Functional proteoliposomes.
    Baldassare JJ; Kahn RA; Knipp MA; Newman PJ
    J Clin Invest; 1985 Jan; 75(1):35-9. PubMed ID: 3155527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.
    Kato Y; Kaneko MK; Kuno A; Uchiyama N; Amano K; Chiba Y; Hasegawa Y; Hirabayashi J; Narimatsu H; Mishima K; Osawa M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1301-7. PubMed ID: 16979138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of rhamnose from ristocetin A removes its ability to induce platelet aggregation.
    Bardsley B; Williams DH; Baglin TP
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):241-4. PubMed ID: 9663706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane glycoproteins and human platelet function.
    Nurden AT; Caen JP
    Br J Haematol; 1978 Feb; 38(2):155-60. PubMed ID: 346047
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
    Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
    Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of platelet aggregation.
    Leung L; Nachman R
    Annu Rev Med; 1986; 37():179-86. PubMed ID: 3010804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.